Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04209465 |
|---|---|
| Brief Title: | A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors. (MasterKey-01) |
| First Submitted : | December 19, 2019 |
| First Submitted that Met QC Criteria : | December 20, 2019 |
| First Posted : | December 24, 2019 |
| Last Update Submitted that Met QC Criteria : | October 13, 2022 |
| Last Update Posted : | October 14, 2022 |